
COX-Prostaglandin Pathway Inhibition May Augment the Effects of Immunotherapy in Breast Cancer
Publication
, Conference
Agarwal, D; Conejo-Garcia, JR; Scholler, J; Tchou, JC
Published in: JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
2020
Duke Scholars
Published In
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
EISSN
1879-1190
ISSN
1072-7515
Publication Date
2020
Volume
231
Issue
4
Start / End Page
S34 / S35
Related Subject Headings
- Surgery
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Agarwal, D., Conejo-Garcia, J. R., Scholler, J., & Tchou, J. C. (2020). COX-Prostaglandin Pathway Inhibition May Augment the Effects of Immunotherapy in Breast Cancer. In JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (Vol. 231, pp. S34–S35).
Agarwal, Divyansh, Jose Ramon Conejo-Garcia, John Scholler, and Julia C. Tchou. “COX-Prostaglandin Pathway Inhibition May Augment the Effects of Immunotherapy in Breast Cancer.” In JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 231:S34–35, 2020.
Agarwal D, Conejo-Garcia JR, Scholler J, Tchou JC. COX-Prostaglandin Pathway Inhibition May Augment the Effects of Immunotherapy in Breast Cancer. In: JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. 2020. p. S34–5.
Agarwal, Divyansh, et al. “COX-Prostaglandin Pathway Inhibition May Augment the Effects of Immunotherapy in Breast Cancer.” JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, vol. 231, no. 4, 2020, pp. S34–35.
Agarwal D, Conejo-Garcia JR, Scholler J, Tchou JC. COX-Prostaglandin Pathway Inhibition May Augment the Effects of Immunotherapy in Breast Cancer. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. 2020. p. S34–S35.

Published In
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
EISSN
1879-1190
ISSN
1072-7515
Publication Date
2020
Volume
231
Issue
4
Start / End Page
S34 / S35
Related Subject Headings
- Surgery
- 3202 Clinical sciences
- 1103 Clinical Sciences